IPO Watch: DeepSeek Seeks Shanghai IPO, Moonshot AI Confidentially Files for Hong Kong Listing, AI IPO Wave Faces Public-Market Test
The AI IPO Wave Is About to Face the Public-Market Test
The next generation of technology IPOs could provide something private markets have largely hidden: a public-market test of AI economics. This week, three signals converged to make that test imminent — DeepSeek has tapped CITIC Securities for a domestic Shanghai STAR Market listing, Anthropic is reportedly approaching a major U.S. IPO, and Moonshot AI has confidentially filed for a Hong Kong listing. Meanwhile, the Tencent-backed AI chipmaker Enflame Technology debuted on Shanghai's STAR Market on September 11 after raising approximately $912 million at a roughly $9.1 billion valuation. The key question is no longer simply which companies are going public — it is whether enormous private AI valuations can survive the transition to public-market scrutiny of cash burn, compute costs, and capital intensity.
Enflame Technology Raises $912M at $9.1B Valuation in First Public Pricing of a Chinese AI-Chip Pure-Play.
Tencent-backed AI chipmaker Enflame Technology debuted on Shanghai's STAR Market on September 11 after raising approximately $912 million at a roughly $9.1 billion valuation. The listing is the first public-market pricing of a Chinese AI accelerator company, arriving as global demand for AI compute hits record highs and Beijing pushes capital-market support for strategic technology self-sufficiency. Enflame's post-debut trading will set the valuation benchmark the rest of the AI IPO pipeline — from DeepSeek to Anthropic — will inevitably be measured against.
DeepSeek Engages CITIC Securities for Domestic STAR Market Listing
China's most prominent open-weight AI lab has tapped CITIC Securities for a domestic IPO, moving toward what would be the first major public-market test of a Chinese frontier-model company. The listing would give public investors their first transparent view into how an open-weight AI business models revenue, compute costs, and gross margins — and a direct read on whether open-weight AI economics can be priced by public markets at scale.
Anthropic Reportedly Approaching Major U.S. IPO — the Defining Test of Frontier-Model Economics
Anthropic is reportedly approaching a major U.S. IPO, in what would be the single most important data point yet for private AI economics. Its public valuation would be a direct comparison between private-market pricing of frontier-model companies and public-market willingness to fund their development at scale. The critical metrics for investors will be compute cost as a percentage of revenue, gross margin trajectory, and R&D intensity — the same factors that determine whether AI companies trade like software or like utilities.
Moonshot AI Confidentially Files for Hong Kong Listing
Moonshot AI has confidentially filed for a Hong Kong listing, testing investor appetite for Chinese AI models in an offshore venue. The Hong Kong filing provides an important comparison point against the STAR Market listings — and would be the first test of whether offshore public investors are willing to price Chinese frontier-model economics differently from onshore investors.
China's Securities Regulators Warn Bankers Against Flooding the IPO Market With "Low-Quality" Companies
China's securities regulators are now urging bankers to avoid flooding the IPO market with lower-quality companies, following outsized first-day gains in several recent technology listings. The guidance is an explicit signal that the AI IPO window is opening — but not unconditionally. Regulators are prioritizing quality, capital discipline, and strategic alignment over raw volume, which will likely slow the pipeline but also improve the quality of listings that actually reach public markets.
U.S. Enterprise AI Companies Evaluating 2027 IPO Windows
The U.S. AI IPO pipeline is building behind Anthropic, with late-stage enterprise AI companies — particularly in AI security, AI infrastructure, and AI deployment platforms — reportedly evaluating 2027 windows. Any one of these listings would provide a critical benchmark for how public investors price enterprise AI deployment economics relative to frontier-model companies. Watch for S-1 filings in late 2026 and early 2027 as the pipeline crystallizes.
AI IPO Class of 2025 Nears Lockup Expirations — a Key Test of Public-Market Demand
Watch the AI IPO class of 2025 for lockup expirations that could introduce insider selling pressure and test public-market demand for AI equities. Lockup expirations are a critical stress test — if insider selling is absorbed smoothly, it signals durable institutional demand for AI listings. If it triggers sharp selloffs, it will complicate pricing for the next wave of AI IPOs, including any 2027 candidates.
Market Impact Analysis
The current AI IPO window reflects a fundamental shift in how public equities evaluate growth-stage technology balance sheets. Investors are prioritizing capital discipline and durable revenue over narrative momentum:
- Compute Cost Is the Metric That Matters: For foundation-model companies, compute expenditure as a percentage of revenue is the single most important ratio. If compute costs consume 60–70% of revenue, there is no plausible path to profitability. Below 40%, and the multiple expands dramatically.
- Software vs. Infrastructure Multiples: AI companies with software-level gross margins (70%+) will trade at software multiples. Those with infrastructure-level gross margins (40–50%) will trade at infrastructure multiples. The difference is 2–3x valuation — and it will be determined by the disclosures in the first major AI IPO prospectuses.
- Geographic Divergence: China is currently the most active AI IPO market globally — driven by state policy support, domestic capital availability, and strategic-tech priority. The U.S. is the most consequential — because whatever Anthropic prices at will define frontier-model economics for the entire market. Europe remains a notable gap with strong private AI funding but no clear near-term public listings.
- Three Possible Outcomes: Validation (public markets accept private AI valuations at or near parity), repricing (public markets price AI companies at a discount — a reset, not a crash), or rejection (public markets reject AI economics outright). The most likely outcome is somewhere between validation and repricing, with strong AI companies trading at premium multiples and weaker ones repriced hard.
IPO Pipeline & Outlook
| Company | Sector | Valuation / Raise | Filing Status | Estimated Window |
|---|---|---|---|---|
| Enflame Technology | AI Chips / Semiconductors | ~$9.1B / $912M raise | Debuted Sept 11 (STAR) | Trading |
| DeepSeek | Foundation Models | TBD | Advisor engaged (CITIC) | 2027 Window |
| Anthropic | Foundation Models | TBD | Reported approaching IPO | 2026–2027 |
| Moonshot AI | Foundation Models | TBD | Confidential filing (HK) | 2026–2027 |
| U.S. Enterprise AI (pipeline) | AI Software & Deployment | TBD | Evaluating 2027 windows | 2027 |
| AI IPO Class of 2025 | Various | — | Lockup expirations pending | Next 1–2 quarters |
The CODEW Take
The AI IPO wave is about to test the public markets — and the outcome will reshape the entire AI capital cycle. Nvidia's recent $12.93 billion acquisition of Hugging Face, Analog Devices' $1.35 billion bet on Alif Semiconductor, and Silver Lake's €10 billion Cegid-Silae merger all point to the same conclusion: strategic capability is now the defining currency of technology competition, and public markets are about to price it directly for the first time. For AI company founders, the window is opening, but discipline matters more than timing — companies that demonstrate a credible path to profitability, controlled compute costs, and durable revenue visibility will price well, while those that rely on narrative alone will be repriced hard. For public-market investors, this is the first opportunity to price frontier AI economics directly — and the critical metrics will be compute cost as a percentage of revenue, gross margin trajectory, and R&D intensity. For regulators, the Enflame and DeepSeek listings on the STAR Market, the Moonshot filing in Hong Kong, and any Anthropic IPO in the U.S. will define how AI listings are regulated in three different jurisdictions — and set precedents that will shape the pipeline for years. Expect more structured consideration, more transparency on AI economics, and more disciplined AI listings as the pipeline builds through 2027.
Source Attribution
- Reuters — China's DeepSeek taps CITIC Securities for domestic IPO: DeepSeek IPO Filing.
- Reuters — Tencent-backed Enflame to debut in Shanghai on Friday in $912 million IPO: Enflame STAR Market Debut
- Financial Times — China warns bankers not to flood IPO market with 'low-quality' companies: IPO Market Quality Guidance.
- SEC EDGAR Filings: U.S. Securities and Exchange Commission — Filings Search
- Forge Global Tech IPO Calendar: 2026 Tech IPO Pipeline & Valuation Metrics
The CODEW IPO Watch examines technology companies entering or preparing to enter the public markets, including IPO filings, valuations, pricing, market debuts, investor appetite, and public-market performance.
Coverage is based on company filings, regulatory disclosures, company announcements, market data, industry research, public reporting, and other publicly available information. IPO timelines, valuations, offering terms, and market conditions can change rapidly. The CODEW's analysis represents editorial research and is not investment advice.
Reviewed by Erwin Castro
on
Thursday, September 10, 2026
Rating:
